 | • レポートコード：MRC2303K140 • 出版社/出版日：Mordor Intelligence / 2023年2月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療機器 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の調査レポートでは、世界の腹腔鏡検査装置市場規模が、予測期間中、CAGR 7.9％で増大すると予測されています。本レポートでは、腹腔鏡検査装置の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（腹腔鏡、吸入装置、手持ち型装置、吸引・灌水装置、その他）分析、用途別（肥満症手術、婦人科外科手術、大腸肛門科手術、その他）分析、エンドユーザー別（外来センター、病院・診療所、その他）分析、地域別（アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン）分析、競争状況、市場機会・将来動向などについて調査・分析などの項目を掲載しています。並び、こちらのレポートには、B. Braun Melsungen AG、Boston Scientific Corporation、ConMed Corporation、Johnson & Johnson (Ethicon Inc.)、Karl Storz GmbH & Co. KG、Medtronic PLC (Covidien)、Olympus Corporation、Richard Wolf GmbH、Smith & Nephew PLC、Stryker Corporationなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の腹腔鏡検査装置市場規模：製品別 - 腹腔鏡の市場規模 - 吸入装置の市場規模 - 手持ち型装置の市場規模 - 吸引・灌水装置の市場規模 - その他腹腔鏡検査装置の市場規模 ・世界の腹腔鏡検査装置市場規模：用途別 - 肥満症手術における市場規模 - 婦人科外科手術における市場規模 - 大腸肛門科手術における市場規模 - その他用途における市場規模 ・世界の腹腔鏡検査装置市場規模：エンドユーザー別 - 外来センターにおける市場規模 - 病院・診療所における市場規模 - その他エンドユーザーにおける市場規模 ・世界の腹腔鏡検査装置市場規模：地域別 - 北米の腹腔鏡検査装置市場規模 アメリカの腹腔鏡検査装置市場規模 カナダの腹腔鏡検査装置市場規模 メキシコの腹腔鏡検査装置市場規模 … - ヨーロッパの腹腔鏡検査装置市場規模 ドイツの腹腔鏡検査装置市場規模 イギリスの腹腔鏡検査装置市場規模 フランスの腹腔鏡検査装置市場規模 … - アジア太平洋の腹腔鏡検査装置市場規模 中国の腹腔鏡検査装置市場規模 日本の腹腔鏡検査装置市場規模 インドの腹腔鏡検査装置市場規模 … - 南米/中東の腹腔鏡検査装置市場規模 南アフリカの腹腔鏡検査装置市場規模 ブラジルの腹腔鏡検査装置市場規模 アルゼンチンの腹腔鏡検査装置市場規模 … ・競争状況 ・市場機会・将来動向 |
The laparoscopy devices market is expected to witness a CAGR of 7.9% during the forecast period.
During the COVID-19 pandemic, hospitals worldwide reduced elective and non-urgent cases to maintain social distancing and avoid transmission of the virus. However, urgent gynecological and cancer procedures were being performed, and it’s critical that all theater staff be safeguarded, and the risk of SARS-CoV-2 viral transmission is minimized when operating on asymptomatic or diagnosed COVID-19 patients. For instance, the Saudi Arabia National Cancer Institute (SANCI) issued a guideline for caregivers and cancer facilities in March 2020 to reduce the impact of COVID-19 on cancer patients. The COVID-19 pandemic has significantly impacted urological care and urologist recruitment in this region. The urology practice has been changed due to the exceptional impact on the healthcare system during the pandemic. According to a 2020 study published in the Dove Press, an increase in delayed urological services during the pandemic resulted in a wait of 8 weeks in outpatient clinics. However, as COVID cases started declining, the number of surgeries performed began returning to the pre-COVID levels.
Certain factors driving the market growth include increasing technological advancements, the growing prevalence of chronic diseases, and the growing demand for minimally-invasive surgery. Minimally-invasive surgeries (MIS) cause less post-operative pain, and hence, patients receive smaller dosages of pain killers. There are minimal cuts or stitches involved, the hospital stay is relatively shorter, and patients need not visit the hospital frequently.
Traditional open surgeries involve long incisions made through the muscles, and these muscles take a considerable amount of time to heal, whereas MIS procedures involve smaller incisions, leading to a quicker recovery. These surgeries have been gaining wider acceptance among the geriatric population due to the relatively shorter recovery time. Few organizations, such as the American Association of Gynecologic Laparoscopists (AAGL) and the International Society of Gynecologic Endoscopy (ISGE), have been collaborating with healthcare agencies in South Africa to create awareness about the benefits of MIS and improve the adoption rate.
The rising prevalence of chronic diseases is driving up the demand for better treatment measures. As a result, the patient pool for chronic diseases is expected to drive the number of surgeries performed, which will aid in the growth of disposable laparoscopy devices. For instance, according to data published by World Health Organization, 2021, cardiovascular diseases account for 17.9 million deaths globally, followed by cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million).
Thus, due to the benefits associated with minimally-invasive surgeries, the adoption rate has been increasing, which may further increase the market’s overall growth over the forecast period.
Laparoscopy Devices Market Trends
Bariatric Surgery Expected to Hold Significant Market Share in the Application Segment
Bariatric surgery or weight loss surgery is one of the major treatment procedures for treating obesity. During this procedure, the size of the stomach is reduced by either removing some parts of the stomach or using a gastric band. Increasing obesity rates among children and adolescents are being witnessed across the globe, leading to several young patients undergoing bariatric surgery.
The increasing bariatric surgical procedures are likely to raise the demand for disposable laparoscopic devices. For instance, according to a research study by Ergie P.Inocian et al., published in Surgery for Obesity and Related Diseases Journal June 2021, there has been an increasing volume of bariatric surgeries in the Middle East to address obesity and metabolic disorders. Thus, bariatric surgical procedures continue to gain acceptance as a treatment for severe obesity in the Middle-East and North Africa regions, which is expected to impact market growth positively.
According to the World Health Organization (WHO), in 2021, across the world, obesity has almost increased three-fold since 1975. In the five–19 age bracket, obesity increased from less than 1% to 7% over the same period. The WHO states that most of the world’s population live in countries where being overweight and obese kills more people than being underweight. Bariatric surgical procedures cause weight loss by restricting the amount of food the stomach can hold, causing malabsorption of nutrients, or combining both gastric restriction and malabsorption. Laparoscopic bariatric surgery is safe in the elderly population, similar to bariatric procedures.
North America Dominates the Market and Expected to Continue Dominance in the Forecast Period
North America is anticipated to dominate the laparoscopy devices market globally. The factors attributed to the region’s high growth are the increasing cases of obesity, various chronic diseases, and the growing adoption of minimally-invasive surgeries.
According to an article published by the Center for Disease Control and Prevention, updated in April 2021, six in ten adults in the US have at least one chronic disease, and four in ten adults have two or more chronic diseases. Thus, the high prevalence of chronic diseases in the country increases the demand for minimally invasive surgeries, thus, driving the laparoscopy devices market.
In addition, organic and inorganic strategies such as mergers and acquisitions and partnerships with key market players are being adopted to strengthen companies’ product portfolios and drive the market studied. Also, several product launches in the market are expected to result in lucrative market growth. For instance, in June 2021, Ethicon, part of the Johnson & Johnson Medical Devices Companies, launched ENSEAL X1 Curved Jaw Tissue Sealer, a new advanced bipolar energy device that increases procedural efficiency and provides stronger sealing and better access to more tissue. The device is indicated for colorectal, gynecological, bariatric surgery, and thoracic procedures.
The advantages of minimally-invasive surgeries, such as less invasiveness, the quick recovery time of patients, and the low cost of treatment, have augmented the demand for laparoscopy devices in the region. Furthermore, advancements in various surgical devices from established players in the US are likely to drive market growth in North America.
Laparoscopy Devices Market Competitor Analysis
The global laparoscopy devices market is highly competitive and consists of a number of major players. Companies, like B. Braun Melsungen AG, Boston Scientific Corporation, ConMed Corporation, Johnson & Johnson (Ethicon Inc.), Karl Storz GmbH & Co.KG, Medtronic PLC (Covidien), Olympus Corporation, Richard Wolf GmbH, Smith & Nephew PLC, and Stryker Corporation, among others, hold a substantial share in the laparoscopy devices market.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Technological Advancements
4.2.2 Growing Prevalence of Chronic Diseases
4.2.3 Growing Demand for Minimally-Invasive Surgery
4.3 Market Restraints
4.3.1 Lack of Expertise in Laparoscopic Surgeries
4.3.2 High Costs Associated with these Devices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD Million)
5.1 Product
5.1.1 Energy Devices
5.1.2 Laparoscopes
5.1.3 Insufflation Devices
5.1.4 Handheld Instruments
5.1.5 Suction/Irrigation Devices
5.1.6 Other Products
5.2 Application
5.2.1 Bariatric Surgery
5.2.2 Gynecological Surgery
5.2.3 Colorectal Surgery
5.2.4 Other Applications
5.3 End User
5.3.1 Ambulatory Centers
5.3.2 Hospitals and Clinics
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 US
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 UK
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 Boston Scientific Corporation
6.1.3 ConMed Corporation
6.1.4 Johnson & Johnson (Ethicon Inc.)
6.1.5 Karl Storz GmbH & Co. KG
6.1.6 Medtronic PLC (Covidien)
6.1.7 Olympus Corporation
6.1.8 Richard Wolf GmbH
6.1.9 Smith & Nephew PLC
6.1.10 Stryker Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS